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Abstract: Marine organisms are an increasingly important source of novel metabolites, 
some of which have already inspired or become new drugs. In addition, many of these 
molecules show a high degree of novelty from a structural and/or pharmacological point of 
view. Structure determination is generally achieved by the use of a variety of spectroscopic 
methods, among which NMR (nuclear magnetic resonance) plays a major role and 
determination of the stereochemical relationships within every new molecule is generally 
the most challenging part in structural determination. In this communication, we have 
chosen okadaic acid as a model compound to perform a computational chemistry study to 
predict 
1
H and 
13
C NMR chemical shifts. The effect of two different solvents and 
conformation on the ability of DFT (density functional theory) calculations to predict the 
correct stereoisomer has been studied. 
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1. Introduction 
Marine natural products have generated great interest within the scientific community due to their 
fascinating biological activities, as well as by their extraordinary molecular diversity that have made 
them challenging problems for structure elucidation [1,2]. Structure determination is mostly achieved 
by interpretation of MS (mass spectrometry) and NMR (nuclear magnetic resonance) data and 
stereochemical assignments are generally the most time consuming step within this procedure [3]. This 
is particularly true when one has the need to assign independent molecular segments containing remote 
stereogenic centers, though it can be done by the use of the 
3
JH,H and 
2,3
JC,H providing an adequate 
number of them can be measured [4]. Asymmetric synthesis of the target molecule and subsequent 
comparison of their NMR spectroscopic data is another valuable and highly used approach, although 
very time consuming. Moreover, it has been proven that nowadays quantum mechanical calculations of 
NMR chemical shifts are also an excellent tool for determining molecular structures [5–8]. 
Two significant restrictions applies for the use of quantum-chemistry methods in structure 
determination, (1) computational limitations, related to the size of the studied system and the accuracy 
of the theoretical approach; and (2) bulk effects, mainly related to the interaction of the studied 
molecule with the solvent. With regard to the first issue, the continuous development of new computer 
facilities and computational methods allows, especially for atoms of the first two rows of the periodic 
table, the use of increasingly extended basis sets at either HF (Hartree-Fock), DFT (density functional 
theory), or post-HF methods, but still is a concern as the molecular size increases or when a large 
number of molecules have to be simulated. Nevertheless, it have been reported that the use of DFT 
methods, with relatively simple basis sets can yield accurate chemical shift predictions [9]. Concerning 
the second point, the effect of solvent on the computation of NMR parameters is relatively complex, as 
the studied molecules can be polarized by electrostatic interactions, make specific bonds, or simply 
change their conformation [10–13]. However, from a practical point of view, solvent effects on 
computed chemical shifts of small molecules dissolved in commonly used NMR solvents such as 
CDCl3 are frequently small [14]. As NMR chemical shifts are strongly affected by molecular 
conformation; geometry optimization is a crucial factor in an accurate computation of NMR chemical 
shifts. Regarding this point, Goodman et al. [15] have reported that, estimates of energy and isotropic 
shielding in solution by DFT methods can be reliably obtained by single-point calculations on the  
gas-phase of structures obtained from faster molecular mechanics conformational searches, thus, 
circumventing the need for time consuming optimizations in solvent. On the other hand, relatively few 
studies have considered the difference between results obtained with and without solvent models,  
but the general conclusion is that consideration of solvent generally leads to an improvement of the  
results [9,16]. 
In this work, we address the question of assigning one set of NMR experimental data to different 
possible structures where two stereoclusters are joined by an acyclic linker. We have chosen okadaic 
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acid (1 in Figure 1) as a structurally representative of a large group of marine toxins—that shares many 
common structural features—including yessotoxins, brevetoxins, ciguatoxins, palytoxins and other 
related compounds, such as amphidinolides, amphidinols, belizenolide, etc. [17–19]. Moreover, the 
structure of okadaic acid has been profusely studied by NMR and X-ray crystallography, and although 
it is a potentially flexible molecule (three acyclic portions can be identified within the molecule) it 
turns out to be conformationally restricted by the existence of an intramolecular H-bond between the 
carboxyl group at C-1 and the hydroxyl at C-24 [20–23]. Finally, okadaic acid is soluble in different 
solvents, so the influence of this parameter on the results of these calculations can also be addressed. 
Figure 1. Structures of okadaic acid (1) and of the studied diasteroisomer (2). 
 
2. Results and Discussion 
Our aim in this study is to verify that quantum mechanics computational simulations provide valid 
support to the structural characterization of the important group of polyether marine toxins, of which 
complex structures are usually elucidated on the basis of NMR spectral data. Thus, in this 
communication, the effect of two different solvents, the use of two different levels of theory and the 
influence of molecular conformation on the ability of DFT calculations to predict the correct 
stereoisomer has been studied. For this purpose, we present a systematic investigation of structure 
assignment using different statistical tools such as correlation coefficient (R
2
), corrected mean absolute 
deviation (CMAD) [5] and DP4 probability [6]. 
2.1. Crystallographic Structure of Okadaic Acid 
The crystallographic structure of okadaic acid was used as our ―gold‖ standard to reference all the 
calculations. Uemura et al. [24] published the structure after crystallization in methanol and the atomic 
coordinates were downloaded from the Cambridge Crystallographic Data Centre [25] under the 
accession number CCDC 691258. 
2.2. Experimental NMR Data of Okadaic Acid 
Accurate 
1
H and 
13
C NMR chemical shift assignments are critical for an appropriate comparison 
between experimental and calculated values. Stereospecific assignments for okadaic acid were 
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available for almost all atoms when using CDCl3 as solvent (except for protons at C-20 and C-35) [23]. 
However, this was not the case when CD3OD is used as solvent, where nonstereospecific assignments 
were only available [21]. For this reason, we accomplished a full assignment of every proton in 
okadaic acid measuring 
3
JHH values and dipolar correlations from a series of 1D-Selective TOCSY and 
NOESY as well as 2D ROESY experiments [26]. NMR data and relevant dipolar correlations are 
summarized in Figure 2 and Table 1. 
Figure 2. Relevant dipolar correlations observed for okadaic acid in CD3OD. 
 
Table 1. 
1
H and 
13
C NMR data for okadaic acid in CD3OD (J in Hz). 
C δC δH 
3
JH,H C δC δH 
3
JH,H 
1 182.2 - - 23 78.1 3.28 9.8, 9.8 
2 76.0 - - 24 71.8 3.92 9.8 
3 46.1 
1.79S  
1.65R 
2.0, 12.0  
11.0, 12.0 
25 146.7 - - 
4 68.2 3.92 2.0, 2.5, 9.0, 11.0 26 86.2 3.80 8.8 
5 33.1 
(β) 1.72R  
(α) 1.30S 
4.0, 9.0, 10.0, 13.0  
2.5, 2,5, 5.0, 13.0 
27 65.8 3.94 2.0, 8.8, 10.0 
6 28.2 
(α) 1.82R  
(β) 1.51S 
4.0, 4.8, 5.0, 13.0  
2.5, 9.5, 10.0, 13.0 
28 36.3 
1.28R  
0.82S 
2.6, 10.0, 12.0  
2.0, 11.0, 12.0 
7 73.2 3.22 4.8, 9.5 29 32.0 1.78 2.6, 6.4, 10.5, 11.0 
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Table 1. Cont. 
8 97.1 - - 30 76.7 3.13 2.2, 10.5 
9 123.5 5.13 - 31 28.5 1.69 2.2, 2.5, 6.5, 6.9 
10 138.8 - - 32 27.5 
(α) 1.88S  
(β) 1.25R 
2.5, 2.5, 12.0, 12.0  
2.0, 6.5, 6.5, 12.0 
11 33.4 
(β) 1.90R  
(α) 1.69S 
11.0, 16.0  
4.0, 16.0 
33 30.6 1.22(2H) - 
12 71.4 3.71 4.0, 8.0, 11.0 34 96.5  - 
13 42.9 2.20 7.0, 8.0, 8.5 35 36.6 
(β) 1.49R  
(α) 1.26S 
2,5, 4.3, 13.0  
2.5, 13.0, 13.0 
14 137.2 5.81 8.5, 15.4 36 19.4 
(α) 1.79S  
(β) 1.40R 
2.5, 2.5, 4.3, 4.3, 13.0  
2.5, 2.5, 13.0, 13.0, 13.0 
15 131.9 5.34 7.9, 15.4 37 26.1 1.37(2H) - 
16 80.2 4.52 7.5, 7.5, 7.9 38 60.9 
(β) 3.57S  
(α) 3.39R 
3.0, 11.5, 12.0  
2.5, 3.0, 12.0 
17 31.0 
(α) 2.04R  
(β) 1.43S 
6.2, 7.5, 9.5, 12.0  
5.0, 5.5, 7.5, 12.0 
39 10.6 0.79 6.9 
18 37.7 
(α) 1.88S  
(β) 1.72R 
5.0,9.5, 12.5  
5.5, 6.2, 12.5 
40 16.8 0.91 6.4 
19 106.5 - - 41 112.6 
5.25  
4.91 
- 
20 33.4 1.75 (2H) - 42 16.9 0.98 7.0 
21 27.5 
(α) 1.75R  
(β) 1.65S 
4.0, 13.0  
10.0, 13.0 
43 22.9 1.59 - 
22 71.1 3.50 4.0, 9.8, 10.0 44 27.5 1.16 - 
2.3. Diasteroisomeric Structure of Okadaic Acid 
In order to test the possibility of differentiating an incorrect diasteroisomer of okadaic acid (2) from 
the correct structure (1), we assembled an alternative molecule where the whole C-29→C-38 
stereocluster was inverted while the C-1→C-28 moiety maintained the same configuration (Figure 3). 
The crystallographic structure of okadaic acid was used as a template where the C-29→C-38 fragment 
was manually reoriented in order to find a similar extended conformation. Afterwards, an unrestrained 
minimization was performed in the previous structure to optimize the geometry. Therefore, the new 
molecule (2) shows the alternate configuration (29R, 30R, 31S, 34R) instead of the right one (29S, 30S, 
31R, 34S). The selection of the C-29→C-38 moiety was based on the fact that it is spatially distant 
from the C-1→C-26 pseudo-macrocyclic portion of the molecule. In this way, we could simulate  
a situation where one has two well-defined stereoclusters but their relative configurations are difficult 
to connect. Indeed, it has been shown that correlating relative configurations of two separated 
―stereoarrangements‖ by NMR and DFT calculations is a fairly challenging task that has to be taken 
with caution [27]. Here, in principle, the introduced structural modifications would not induce large 
differences in the calculated chemical shifts, as changes in their chemical environments are minor.  
In addition, an acyclic linker connects the C-1→C-26 and C-29→C-38 stereoclusters and 
consequently, the effects of conformational flexibility could be tested. 
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Figure 3. Crystallographic structure of okadaic acid in blue superimposed with the studied 
29R, 30R, 31S, 34R diasteroisomer in red. 
 
2.4. Conformational Searches 
The crystal structure of okadaic acid was used as a starting template for the conformational 
searches. Simulations were performed using the OPLS2005 force field [28], as implemented in 
MacroModel 9.9 [29] using the generalized Born/surface area (GBSA) solvent model. Searches were 
undertaken using the mixed torsional and low-mode sampling scheme [30], and all local minima found 
within 10 kJ of the global minimum were used in the DFT calculations. 
2.5. Calculation of NMR Chemical Shifts 
Based on previously reported results, we decided to use two of the most popular hybrid functionals, 
the B3LYP [31–34] and the mPW1PW91 [35] with the 6 − 31 + G * basis set to calculate the isotropic 
chemical shielding values for all atoms within okadaic acid (1) and its diasteroisomer (2). In order to 
calculate the empirically scaled chemical shifts (δscaled), we plot the experimental values measured 
either in CDCl3 or CD3OD against the theoretically calculated isotropic shieldings (Figure 4). 
Afterwards, the intercept (a) and the slope (b) of the regression line were used to calculated the scaled 
chemical shifts as δscaled = (δexp − a)/b. Using this approach, systematic errors can be compensated as 
the obtained values do not depend fundamentally on the calculation of one particular molecule, such as 
TMS (tetramethylsilane) [7]. 
We started all our calculations with the crystallographic structure of okadaic acid. Using its atomic 
coordinates, isotropic shieldings were calculated and subsequently scaled computed chemical shifts 
(δscaled) were empirically obtained. This was done by applying linear regression parameters obtained 
from the plot of isotropic shieldings against the experimental chemical shifts (δexp), as it can be seen in 
Figure 4. In this way, systematic errors, caused by an inaccurate reference value, can be avoided.  
This approach has been proposed as appropriate to remove systematic errors [7]. Alternatively,  
generic-scaling factors obtained from large datasets can be used, however, the results obtained were 
slightly worse. For instance, 
13
C and 
1
H CMAD values of 2.57 ppm and 0.27 ppm (chloroform) or  
2.35 ppm and 0.23 ppm (methanol), respectively, were obtained using generic parameters taken from 
the CHESHIRE webpage [36] at the B3LYP/631G + (d,p) level in the gas phase as oppose to  
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13
C and 
1
H CMADs of 1.90 ppm and 0.25 ppm in chloroform or 1.93 ppm and 0.22 ppm in methanol, 
respectively, when we used specific scaling factors obtained as described above. 
Figure 4. 
1
H correlations (a) and 
13
C correlations (b) between calculated isotropic 
shieldings and experimental chemical shifts of okadaic acid. Fitting parameters are 
indicated for each nucleus. 
a b 
  
The computed chemical shifts—either in the gas phase or using the Poisson Boltzmann finite (PBF) 
element method solvation model for chloroform or methanol—are shown in Tables 2 and 3. 
Table 2. Experimental and computed δ 13C for okadaic acid and the studied diasteroisomer. 
C 
1-Gas  
(CDCl3) 
1-CHCl3  
(CDCl3) 
2-Gas  
(CDCl3) 
2-CHCl3  
(CDCl3) 
Expt  
(CDCl3) 
Expt  
(CD3OD) 
1-Gas  
(CD3OD) 
1-CH3OH  
(CD3OD) 
2-Gas  
(CD3OD) 
2-CH3OH  
(CD3OD) 
1 178.7 179.5 172.9 172.5 177.1 182.2 180.2 180.7 174.3 176.0 
2 76.2 76.5 73.9 74.8 77.0 76.0 76.8 77.1 74.5 75.8 
3 42.1 42.1 43.2 43.0 42.8 46.1 42.4 42.2 43.4 43.0 
4 66.8 67.6 68.3 68.0 69.8 68.2 67.3 68.1 68.8 67.8 
5 31.1 31.3 30.9 30.7 32.0 33.1 31.3 31.4 31.1 30.9 
6 31.2 31.3 35.3 35.7 27.5 28.2 31.4 31.5 35.5 35.9 
7 73.1 72.4 71.4 71.0 72.0 73.2 73.7 72.8 71.9 71.2 
8 94.8 94.4 94.5 93.6 97.0 97.1 95.6 95.1 95.2 93.0 
9 123.5 120.2 123.3 120.2 121.9 123.5 124.5 119.7 124.3 118.7 
10 138.3 140.9 138.4 141.7 139.9 138.8 139.4 143.9 139.5 144.0 
11 34.5 34.6 31.6 31.3 33.6 33.4 34.7 35.0 31.8 31.6 
12 70.1 69.7 67.5 68.3 72.0 71.4 70.7 70.5 68.0 67.5 
13 46.3 45.9 46.2 45.7 42.6 42.9 46.6 46.2 46.5 46.1 
14 136.3 136.8 134.0 135.0 136.9 137.2 137.4 139.1 135.1 135.3 
15 134.2 133.4 139.6 138.5 131.8 131.9 135.3 133.6 140.8 138.2 
16 76.6 76.5 74.9 75.2 79.6 80.2 77.2 76.8 75.5 75.3 
17 30.6 30.6 29.0 28.9 31.1 31.0 30.8 30.6 29.2 29.0 
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Table 2. Cont. 
18 36.7 36.9 33.1 33.3 37.7 37.7 36.9 37.3 33.3 33.5 
19 101.9 101.8 104.1 103.4 106.1 106.5 102.7 102.6 104.9 104.2 
20 35.9 35.6 35.7 35.6 33.2 33.4 36.1 35.8 36.0 35.8 
21 26.3 26.2 26.5 26.6 27.0 27.5 26.5 26.3 26.6 26.9 
22 72.4 72.5 72.9 70.1 70.2 71.1 72.9 72.8 73.5 70.3 
23 75.5 75.3 73.1 72.5 76.9 78.1 76.1 75.9 73.7 73.4 
24 72.7 72.4 72.9 72.7 71.6 71.8 73.3 73.0 73.4 73.8 
25 152.3 151.4 148.8 149.8 145.2 146.7 153.5 151.9 150.0 152.6 
26 87.6 87.0 90.9 89.6 85.3 86.2 88.3 87.5 91.6 90.9 
27 63.0 63.1 72.3 71.1 65.0 65.8 63.5 63.5 72.8 71.8 
28 33.9 34.1 38.5 39.9 35.7 36.3 34.1 34.4 38.7 40.9 
29 33.7 33.8 41.9 41.6 31.5 32.0 33.9 34.3 42.2 41.9 
30 74.1 74.4 72.5 74.6 75.5 76.7 74.7 74.9 73.1 75.3 
31 29.9 29.9 34.3 34.6 27.8 28.5 30.1 30.0 34.5 34.9 
32 26.6 26.8 23.5 24.9 26.8 27.5 26.8 27.0 23.6 25.1 
33 31.8 32.0 29.4 29.4 30.8 30.6 32.0 32.2 29.5 29.8 
34 91.6 92.2 93.6 93.9 96.0 96.5 92.3 93.0 94.3 94.8 
35 38.2 38.6 37.5 37.7 36.3 36.6 38.4 39.0 37.7 38.2 
36 21.7 21.8 21.1 22.0 19.2 19.4 21.8 22.0 21.2 22.2 
37 27.3 27.9 25.3 26.4 25.9 26.1 27.5 28.1 25.5 26.7 
38 60.7 60.7 58.2 58.5 60.8 60.9 61.1 61.3 58.6 59.3 
39 10.6 10.5 12.0 12.3 11.1 10.6 10.6 10.5 12.0 12.4 
40 15.1 14.8 13.0 12.4 16.6 16.6 15.2 14.7 13.0 12.7 
41 109.8 110.4 117.5 118.3 113.0 112.6 110.7 111.8 118.5 118.8 
42 15.9 15.6 12.4 11.9 16.3 16.9 16.0 15.6 12.4 12.2 
43 22.3 22.1 20.3 20.0 23.5 22.9 22.4 22.1 20.4 20.1 
44 24.6 25.1 20.3 19.8 27.7 27.5 24.7 25.3 20.4 19.2 
1-gas (CDCl3): δscaled computed for 1 in the gas phase and scaled against experimental data obtained in CDCl3 solution.  
1-CHCl3 (CDCl3): δscaled computed for 1 using a CHCl3 solvation model and scaled against experimental data obtained in 
CDCl3 solution. 2-gas (CDCl3): δscaled computed for 2 in the gas phase and scaled against experimental data obtained in 
CDCl3 solution. 2-CHCl3 (CDCl3): δscaled computed for 2 using a CHCl3 solvation model and scaled against experimental 
data obtained in CDCl3 solution. Expt (CDCl3): Experimental NMR data of 1 obtained in CDCl3 solution. Expt (CD3OD): 
Experimental NMR data of 1 obtained in CD3OD solution. 1-gas (CD3OD): δscaled computed for 1 in the gas phase and 
scaled against experimental data obtained in CD3OD solution. 1-CH3OH (CD3OD): δscaled computed for 1 using a CH3OH 
solvation model and scaled against experimental data obtained in CD3OD solution. 2-gas (CD3OD): δscaled computed for 2 
in the gas phase and scaled against experimental data obtained in CD3OD solution. 2-CH3OH (CD3OD): δscaled computed 
for 2 using a CH3OH solvation model and scaled against experimental data obtained in CD3OD solution. 
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Table 3. Comparison of experimental and computed δ 1H for okadaic acid. 
C 
1-Gas  
(CDCl3) 
1-CHCl3  
(CDCl3) 
2-Gas  
(CDCl3) 
2-CHCl3  
(CDCl3) 
Expt  
(CDCl3) 
Expt  
(CD3OD) 
1-Gas  
(CD3OD) 
1-CH3OH  
(CD3OD) 
2-Gas  
(CD3OD) 
2-CH3OH  
(CD3OD) 
H3 * 1.43 1.54 1.59 1.56 1.62 1.65 1.35 1.49 1.52 1.35 
H3 † 1.83 1.83 1.46 1.61 2.12 1.79 1.75 1.75 1.39 1.86 
H4 4.20 4.24 3.71 3.95 3.96 3.92 4.15 4.16 3.63 3.62 
H5 † 1.45 1.36 1.21 1.35 1.31 1.30 1.37 1.25 1.14 1.14 
H5 * 1.17 1.36 1.96 1.94 1.72 1.72 1.08 1.34 1.89 1.84 
H6 † 1.69 1.66 1.86 1.59 1.83 1.51 1.62 1.54 1.80 1.41 
H6 * 2.16 2.08 1.87 2.06 1.79 1.82 2.09 1.93 1.80 1.71 
H7 3.38 3.65 3.10 3.21 3.34 3.22 3.32 3.65 3.03 3.00 
H9 5.71 5.60 5.50 5.51 5.29 5.13 5.68 5.41 5.42 5.22 
H11 * 1.54 1.61 1.71 1.80 1.87 1.90 1.46 1.65 1.64 1.89 
H11 † 1.66 1.80 1.45 1.76 1.91 1.69 1.58 1.80 1.38 1.45 
H12 3.72 3.37 3.97 4.03 3.35 3.71 3.67 3.29 3.89 4.09 
H13 1.65 1.85 1.51 2.16 2.21 2.20 1.57 1.88 1.44 1.65 
H14 5.26 5.23 5.37 5.29 5.63 5.81 5.23 5.24 5.29 5.13 
H15 5.10 5.17 5.60 5.70 5.42 5.34 5.06 5.15 5.52 5.22 
H16 4.52 4.48 4.14 4.03 4.51 4.52 4.47 4.31 4.06 3.90 
H17 1.48 1.61 1.91 1.92 1.54 1.43 1.40 1.51 1.84 1.73 
H17 * 1.96 2.01 1.30 1.48 2.14 2.04 1.89 1.89 1.23 1.42 
H18 † 2.05 1.95 1.96 1.99 2.04 1.88 1.98 1.78 1.89 1.82 
H18 * 1.85 1.95 1.76 1.90 1.80 1.72 1.77 1.91 1.69 1.95 
H20 * 1.84 1.87 1.75 1.75 1.47 1.75 1.76 1.83 1.68 1.70 
H20 † 1.90 1.96 1.74 1.70 1.32 1.75 1.83 1.84 1.67 1.60 
H21 † 1.78 1.82 1.78 1.55 1.81 1.65 1.70 1.78 1.71 1.35 
H21 * 2.17 2.05 2.28 1.99 1.72 1.75 2.10 1.89 2.21 1.82 
H22 3.56 3.55 4.58 4.17 3.57 3.50 3.51 3.57 4.50 4.15 
H23 3.68 3.70 3.77 3.62 3.35 3.28 3.62 3.60 3.70 3.62 
H24 4.43 4.36 4.07 4.00 4.07 3.92 4.38 4.36 4.00 4.15 
H26 3.87 3.93 4.16 4.34 3.90 3.80 3.82 3.97 4.08 4.71 
H27 4.30 4.35 5.77 5.48 4.04 3.94 4.25 4.32 5.69 5.61 
H28 * 1.11 1.08 1.83 1.63 1.28 1.28 1.03 1.07 1.76 1.64 
H28 † 0.75 0.60 0.84 1.08 0.95 0.82 0.66 0.53 0.78 1.19 
H29 2.55 2.24 1.59 1.61 1.91 1.78 2.49 2.06 1.52 1.65 
H30 3.52 3.49 3.22 3.45 3.25 3.13 3.46 3.42 3.15 3.38 
H31 1.75 1.72 1.40 1.57 1.75 1.69 1.67 1.68 1.34 1.49 
H32 * 1.10 1.18 1.68 1.64 1.86 1.25 1.01 1.12 1.61 1.30 
H32 † 2.22 2.05 0.84 1.05 1.96 1.88 2.15 1.88 0.77 0.84 
H33 * 1.54 1.63 0.51 0.90 1.34 1.22 1.46 1.56 0.45 0.67 
H33 † 1.03 1.13 1.50 1.58 1.52 1.22 0.94 1.02 1.43 1.53 
H35 † 1.53 1.50 2.04 1.74 1.31 1.26 1.45 1.39 1.97 1.68 
H35 * 1.28 1.44 0.69 1.07 1.48 1.49 1.20 1.38 0.63 0.95 
H36 † 1.30 1.32 1.56 1.42 1.61 1.79 1.21 1.26 1.49 1.35 
H36 * 2.21 2.03 2.62 2.29 1.39 1.40 2.14 1.89 2.55 2.24 
H37 † 1.44 1.33 1.17 1.49 1.51 1.37 1.36 1.27 1.11 1.30 
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Table 3. Cont. 
H37 * 1.47 1.58 1.50 1.35 1.84 1.37 1.39 1.48 1.44 1.26 
H38 † 3.88 3.75 3.72 3.53 3.62 3.57 3.83 3.67 3.65 3.49 
H38 * 3.44 3.54 2.65 3.14 3.53 3.39 3.39 3.49 2.58 3.10 
H39 0.99 0.92 1.22 1.20 0.88 0.79 0.90 0.81 1.16 1.12 
H40 1.11 0.95 2.08 1.61 1.01 0.91 1.02 0.88 2.01 1.55 
H41 4.60 4.81 4.34 4.44 5.02 4.91 4.56 4.87 4.26 4.67 
H41 5.22 5.11 5.23 5.19 5.39 5.25 5.18 5.07 5.16 5.08 
H42 0.80 0.82 0.90 0.73 0.97 0.98 0.71 0.76 0.83 0.91 
H43 1.68 1.70 1.65 1.77 1.73 1.59 1.61 1.64 1.58 1.64 
H44 1.28 1.28 1.51 1.40 1.36 1.16 1.20 1.18 1.44 1.29 
Stereoheterotopic hydrogens are identified as pro-R (*) or pro-S (†). Headings are equal to those in Table 2. 
There is an overall good and similar agreement between experimental and computed values as can 
be deduced from the corresponding average errors. Thus, the corrected mean absolute deviations: 
CMAD = (1/n)  δscaled − δexp (1) 
obtained for 
1
H and 
13
C were 0.25 ppm and 1.89 ppm or 0.24 ppm and 1.84 ppm, respectively when 
the gas phase calculations were compared with the experimental values measured in CDCl3 or CD3OD 
respectively (Table 4). Very similar results were obtained using the mPW1PW91/6 − 31 + G * level of 
theory. It is also apparent from the results that calculations done using solvation models produced 
better results than those performed in the gas phase, particularly for 
1
H chemical shifts. Smaller 
CMADs were obtained when the experimental data was compared against the computed values using 
the corresponding solvation model: 0.21 ppm for 
1
H and 1.80 ppm for 
13
C were found when using 
chloroform and similar values of 0.21 ppm for 
1
H and 1.94 ppm for 
13
C using methanol. The 
correlation coefficients R
2
 are also fairly informative, thus when the gas phase calculated values are 
correlated with the experimental data measured in solution, the quality of the correlation is slightly 
lower than those obtained when the computed values including a solvation model are used (Table 4). 
The same procedure was followed for diasteroisomer 2, obtaining parallel trends with those 
observed for 1, i.e., only minor improvements taking into account solvent effects and comparable 
errors at the two different levels of theory used (Supplementary Information). However, larger CMAD 
values and smaller correlation coefficients R
2
 were obtained in all circumstances as can be seen in Table 4. 
Table 4. Summary of the statistical analyses performed. 
Structure 
13
C B3LYP 
1
H B3LYP 
13
C mPW1PW91
 1
H mPW1PW91
 
CMAD R
2
 DP4 CMAD R
2
 DP4 CMAD R
2
 DP4 CMAD R
2
 DP4 
CHCl3 as Solvent 
1gas (A) 1.89 0.9969 - 0.25 0.9465 - 1.81 0.9969 - 0.24 0.9499 - 
2gas (B) 3.29 0.9907 - 0.38 0.8677 - 3.18 0.9917 - 0.35 0.8904 - 
A vs. B - - 100 - - 100 - - 100 - - 100 
1CHCl3 (C) 1.80 0.9972 - 0.22 0.9598 - 1.67 0.9973 - 0.21 0.9623 - 
2CHCl3 (D) 3.21 0.9909 - 0.28 0.9222 - 3.10 0.9916 - 0.26 0.9346 - 
C vs. D - - 100 - - 100 - - 100 - - 100 
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Table 4. Cont. 
1CH3OH (E) 1.89 0.9972 - 0.22 0.9539 - 1.78 0.9971 - 0.23 0.9565 - 
2CH3OH (F) 3.31 0.9903 - 0.34 0.9170 - 3.09 0.9908 - 0.27 0.9300 - 
E vs. F - - 100 - - 100 - - 100 - - 100 
CS I (G) 2.08 0.9958  0.31 0.9268  1.95 0.9961 - 0.27 0.9365 - 
G vs. B - - 100 - - 100 - - 100 - - 100 
CS II (H) 2.35 0.9914 - 0.32 0.9229 - 2.22 0.9923 - 0.31 0.9365 - 
H vs. B - - 100 - - 100 - - 100 - - 100 
CH3OH as solvent 
1gas (I) 1.84 0.9970 - 0.24 0.9415 - 1.78 0.997 - 0.24 0.9445 - 
2gas (J) 3.32 0.9904 - 0.34 0.8893 - 3.22 0.9914 - 0.30 0.9099 - 
I vs. J - - 100 - - 100 - - 100 - - 100 
1CH3OH (K) 1.94 0.9969 - 0.21 0.9596  1.88 0.997 - 0.21 0.9589 - 
2CH3OH (L) 3.51 0.9899 - 0.29 0.9163 - 3.28 0.9909 - 0.21 0.9513 - 
K vs. L - - 100 - - 100 - - 100 - - 100 
1CHCl3 (M) 1.93 0.9971 - 0.23 0.9639 - 1.81 0.9973 - 0.22 0.9626 - 
2CHCl3 (N) 3.43 0.9903 - 0.25 0.9039 - 3.32 0.9917 - 0.23 0.9389 - 
M vs. N - - 100 - - 100 - - 100 - - 100 
CS I (O) 1.75 0.9971 - 0.30 0.9299 - 1.68 0.9973 - 0.27 0.9396 - 
O vs. J - - 100 - - 100 - - 100 - - 100 
CS II (P) 2.58 0.9913 - 0.30 0.9201 - 2.46 0.9921 - 0.27 0.9329 - 
P vs. J - - 100 - - 100 - - 100 - - 100 
1gas: δscaled computed for 1 in the gas phase and scaled vs. experimental data obtained in CDCl3 solution; 2gas: δscaled 
computed for 2 in the gas phase and scaled vs. experimental data obtained in CDCl3 solution; 1CHCl3: δscaled computed for 
1 using a CHCl3 solvation model and scaled vs. experimental data obtained in CDCl3 solution; 2CHCl3: δscaled computed for 
2 using a CHCl3 solvation model and scaled vs. experimental data obtained in CDCl3 solution; 1CH3OH: δscaled computed 
for 1 using a CH3OH solvation model and scaled vs. experimental data obtained in CDCl3 solution; 2CH3OH: δscaled 
computed for 2 using a CH3OH solvation model and scaled vs. experimental data obtained in CDCl3 solution; CS I: δscaled 
computed for conformers obtained in conformational search I (CSI) in the gas phase and scaled vs. experimental data 
obtained in CDCl3 solution; CS II: δscaled computed for conformers obtained in conformational search II (CSI) in the gas 
phase and scaled vs. experimental data obtained in CDCl3 solution; 1gas: δscaled computed for 1 in the gas phase and scaled 
vs. experimental data obtained in CD3OD solution; 2gas: δscaled computed for 2 in the gas phase and scaled vs. experimental 
data obtained in CD3OD solution; 1CH3OH: δscaled computed for 1 using a CH3OH solvation model and scaled vs. 
experimental data obtained in CD3OD solution; 2CH3OH: δscaled computed for 2 using a CH3OH solvation model and scaled 
vs. experimental data obtained in CD3OD solution; 1CHCl3: δscaled computed for 1 using a CHCl3 solvation model and 
scaled vs. experimental data obtained in CD3OD solution; 2CHCl3: δscaled computed for 2 using a CHCl3 solvation model 
and scaled vs. experimental data obtained in CD3OD solution; CS I: δscaled computed for conformers obtained in 
conformational search I (CSI) in the gas phase and scaled vs. experimental data obtained in CDCl3 solution; CS II: δscaled 
computed for conformers obtained in conformational search II (CSI) in the gas phase and scaled vs. experimental data 
obtained in CDCl3 solution. 
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From the previous statistical analysis a selection of the correct stereoisomer looks possible. Still,  
a critical part in any structure prediction using chemical shift calculations relies in the quantification of 
the fit obtained for each possible calculated structure. For this purpose, Smith and Goodman have 
shown that using the DP4 probability analysis it is feasible to assign stereochemical relationships with 
quantifiable confidence [5]. This approach takes the error probabilities for each computed chemical 
shift and, subsequently, using the Bayes theorem, it transforms their product into an overall probability 
that the structure is right. Indeed, when we compared the scaled 
1
H and 
13
C chemical shifts (δscaled) of  
1 and 2 calculated in the gas phase with the experimentally observed values either in chloroform or in 
methanol it turned out that the DP4 analysis always identified the correct structure (1) as the most 
likely one, with a 100% probability (Table 4). Therefore, it seems that despite the use of solvation 
models in the calculations improves the quality of the computed values, (Table 4) the DP4 analysis is 
equally able to select the right stereoisomer with great confidence taking into account the solvents or 
not. This result is in agreement with previously reported observations [15,37], and it is probably due to 
the fact that chemical shift differences are calculated more accurately than the shifts themselves 
because of the cancellation of systematic errors. Moreover, comprehensive studies considering the 
solvent influence in this type of calculations have concluded its impact on chemical shifts is mainly of 
indirect nature as the nature of solvent affects conformational populations and subsequently the 
shielding constants [12,13]. Actually, although both structures (1 and 2) improved their data quality 
when solvation models were considered, no overall advantage in the capability to discriminate the 
correct structure is gained when using the DP4 analysis [38]. 
Up to this point, all our calculations have been done using a single, static structure, that is, using the 
crystallographic coordinates of okadaic acid and comparing them with those generated for its 
diasteroisomer 2. Therefore, we have not taken into consideration that okadaic acid has several 
conformational degrees of freedom in its three acyclic moieties at C-1→C-4, C-12→C-16, and 
C26→C30. How good would the results be using a group of structures obtained from a molecular 
mechanics conformational search? What would happen if the conformational search was not good 
enough to find the global minimum? Although, an analysis of X-ray data and NMR coupling constants 
indicate that okadaic acid seems to be conformationally restricted by the existence of an intramolecular 
H-bond between the carboxyl group at C-1 and the hydroxyl at C-24 (Table 1) [19–21], we also 
wanted to check the importance of conformation in a chemical shift based analysis. Thus, we generated 
two ensembles of structures for 1; the first one (CS I) was the result of a large-enough conformational 
search where the selected structures are in agreement with the NMR data (
3
JH,H and dipolar 
correlations) and the second group (CS II) resulted from a short conformational search where the  
C-25→C-28 dihedral angle resulted incompatible with the NMR data (Figure 5). 
When 
1
H and 
13
C chemical shifts, computed using the structures obtained from both conformational 
searches (CS I and CS II), were compared with the data calculated for 2, it turned out that in all 
circumstances, the DP4 analysis selected the correct stereoisomer with 100% probabilities (Table 4). 
Nevertheless, as expected, the quality of the results obtained from CS I is better than those obtained 
from CS II. Thus, the CMADs obtained using the structures of CS I are smaller than those of CS II,  
in particular for 
13
C chemical shifts. Likewise, the corresponding correlation coefficients R
2
 follow the 
same trend, these are better results for CS I than for CS II (Table 4). 
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Figure 5. Crystallographic structure of okadaic acid (blue) superimposed with the 
energetically representative structures obtained from two conformational searches. 
Structures of an NMR compatible search (CS I) are in greenish and those obtained from an 
incompatible search (CS II) in reddish. 
  
3. Experimental Section  
3.1. Instrumentation and General Methods 
NMR spectra were recorded on a Bruker AVANCE III 600 instrument equipped with a 5 mm  
TCI cryoprobe (Bruker, Rheinstetten, Germany). NMR spectra were obtained dissolving okadaic acid 
in CD3OD (99.8 + atom% D, Eurisotope) and CDCl3 (99.5 atom% D, Eurisotop). Chemical shifts are 
reported relative to solvent: CDCl3 (δH 7.26 and δC 77.0 ppm); CD3OD (δH 3.16, 4.75 and  
δC 48.3 ppm) at 300 K and coupling constants were calculated in Hz. NMR assignments were obtained 
from examination of 1D and 2D experiments (
1
H, 
13
C, DQF-COSY and HSQC). Spectral widths of 
4200 and 22,500 Hz, and acquisition times of 0.57 and 0.24 s, were used in 
1
H-
1
H and 
1
H-
13
C 
experiments, respectively. Prior to Fourier transformation, zero filling was performed to expand the 
data to at least double the number of acquired data points. Sine bell shifted or exponential window 
functions with line broadening coefficients ranging from 0.1 to 3 Hz were used for 2D and 1D 
experiments respectively. HPLC analyses were performed on a Waters instrument equipped with a 
differential diffractometer detector and an X-Terra column. TLCs were carried out using Si gel Merck 
60G, and were visualized with 10% phosphomolybdic acid in ethanol. 
3.2. Prorocentrum Belizeanum Cultures 
The strain of the dinoflagellate P. belizeanum used in this work (PBMA01), originally isolated from 
a coral reef of La Reunion Island, Indian Ocean, France, was obtained from the culture collection of 
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phytoplankton cultures at the Centro Oceanográfico at Vigo, courtesy of Santiago Fraga (country). 
Cultures of P. belizeanum were grown in 250 mL flasks containing 150 mL of sea water enriched with 
Guillard K medium at 23 °C, at a salinity of 35, with an irradiance of 60 μE s−1 m−2 and under a 18:6 
light:darkness photo cycle. Cultures were incubated statically for 6 weeks up to a final volume of 1.5 L. 
3.3. Extraction and Isolation of Okadaic Acid 
The cells from labelled cultures were filtered and extracted with methanol. The extract was 
chromatographed on Sephadex LH 20 using methanol as eluent. The fractions that containing the 
enriched toxin were chromatographed on reverse phase C-18 and the final purification was carried out 
in a HPLC Water instrument using a XTerra column eluted with methanol:water 4:1. 
3.4. Computational Methods 
Conformational searches were performed using the Macromodel software (version 8.5,  
Schrödinger Inc., San Diego, CA, USA) and the OPLS2005 force field [28,29]. Solvation effects were 
simulated using the generalized Born/surface area (GBSA) solvation model with chloroform or 
methanol. Extended nonbonded cutoff distances (a van der Waals cutoff of 8.0 Å and an electrostatic 
cutoff of 20.0 Å) were used. Local minima within 10 kJ of the global minimum were saved. Analysis of 
the results was undertaken using Maestro software.  
Quantum mechanical calculations were carried out with Jaguar package (Jaguar; Schrödinger LLC, 
New York, NY, USA). Single point energy calculations were performed at the DFT theoretical level 
either in gas phase of using a Poisson-Boltzmann finite element method solvation model.  
B3LYP [31–34] and the mPW1PW91 [35] hybrid functionals with the 6 − 31G + (d) basis set were 
used. Chemical shifts were calculated using the gauge-including atomic orbital (GIAO) method [39]. 
Chemical shifts were calculated from their shielding constants that were first averaged according to 
their relative Boltzmann populations. Proton chemical shifts for each methyl group were averaged due 
to their conformational freedom. 
4. Conclusions 
We have tested the importance of various factors that can influence the results obtained in the 
calculation of 
1
H and 
13
C chemical shifts using an archetype of polyether marine toxin, okadaic acid. 
Quantum mechanical calculations using density functional theory can predict chemical shifts to  
a good-enough degree of accuracy to resolve many structural determination problems in this type of 
molecules. This includes challenging situations that arise when one has to decide between different 
stereoisomers containing remote stereogenic centers, where nuclei closest to the sites of major 
structural difference do not always show the largest differences in calculated shift.  
A first conclusion is that the use of very large basis sets in these calculations it is not absolutely 
necessary [9]. In this study we have been able to select the correct diasteroisomer in a complex 
situation using the relatively modest 6 − 31 + G *. The inclusion of solvent effects in the calculations 
generally improve the quality of the results, but as all calculated structures do it, no overall advantage 
in the capability to discriminate the correct structure is gained. This it is probably due to the fact that 
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chemical shift differences are calculated more accurately than the shifts themselves because of the 
cancellation of systematic errors [37,38]. With regard to the effect of conformational variability on the 
results of this kind of analysis, very similar CMADs were obtained using either the X-ray derived 
structure or an ensemble of structures obtained from an appropriate conformational search (the 
structures were in agreement with NMR derived dihedral angles and distances). However, when  
an ensemble of structures including a C25–C28 dihedral angle incompatible with NMR data was used, 
the quality of the fitting diminished but was still better than those obtained using the inappropriate 
diasteroisomer (2). Our results suggest that although the relationship between structural modifications 
and chemical shift differences is complex analyses based on quantum mechanical calculations of NMR 
chemical shifts is robust enough to help with structure elucidation of complex natural products. 
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